Pentland Medical Ltd. - Accounts to registrar (filleted) - small 18.2

Pentland Medical Ltd. - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.2.0.376 SC223422 Board of Directors 1.1.20 31.12.20 31.12.20 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC2234222019-12-31SC2234222020-12-31SC2234222020-01-012020-12-31SC2234222018-12-31SC2234222019-01-012019-12-31SC2234222019-12-31SC223422ns16:Scotland2020-01-012020-12-31SC223422ns15:PoundSterling2020-01-012020-12-31SC223422ns11:Director12020-01-012020-12-31SC223422ns11:PrivateLimitedCompanyLtd2020-01-012020-12-31SC223422ns11:SmallEntities2020-01-012020-12-31SC223422ns11:AuditExempt-NoAccountantsReport2020-01-012020-12-31SC223422ns11:SmallCompaniesRegimeForDirectorsReport2020-01-012020-12-31SC223422ns11:SmallCompaniesRegimeForAccounts2020-01-012020-12-31SC223422ns11:FullAccounts2020-01-012020-12-31SC22342212020-01-012020-12-31SC223422ns11:Director22020-01-012020-12-31SC223422ns11:Director32020-01-012020-12-31SC223422ns11:RegisteredOffice2020-01-012020-12-31SC223422ns6:CurrentFinancialInstruments2020-12-31SC223422ns6:CurrentFinancialInstruments2019-12-31SC223422ns6:Non-currentFinancialInstruments2020-12-31SC223422ns6:Non-currentFinancialInstruments2019-12-31SC223422ns6:ShareCapital2020-12-31SC223422ns6:ShareCapital2019-12-31SC223422ns6:RetainedEarningsAccumulatedLosses2020-12-31SC223422ns6:RetainedEarningsAccumulatedLosses2019-12-31SC223422ns6:IntangibleAssetsOtherThanGoodwill2020-01-012020-12-31SC223422ns6:PatentsTrademarksLicencesConcessionsSimilar2020-01-012020-12-31SC223422ns6:PlantMachinery2020-01-012020-12-31SC223422ns6:FurnitureFittings2020-01-012020-12-31SC223422ns6:MotorVehicles2020-01-012020-12-31SC223422ns6:ComputerEquipment2020-01-012020-12-31SC223422ns6:NetGoodwill2019-12-31SC223422ns6:IntangibleAssetsOtherThanGoodwill2019-12-31SC223422ns6:NetGoodwill2020-01-012020-12-31SC223422ns6:NetGoodwill2020-12-31SC223422ns6:IntangibleAssetsOtherThanGoodwill2020-12-31SC223422ns6:NetGoodwill2019-12-31SC223422ns6:IntangibleAssetsOtherThanGoodwill2019-12-31SC223422ns6:PlantMachinery2019-12-31SC223422ns6:FurnitureFittings2019-12-31SC223422ns6:MotorVehicles2019-12-31SC223422ns6:ComputerEquipment2019-12-31SC223422ns6:PlantMachinery2020-12-31SC223422ns6:FurnitureFittings2020-12-31SC223422ns6:MotorVehicles2020-12-31SC223422ns6:ComputerEquipment2020-12-31SC223422ns6:PlantMachinery2019-12-31SC223422ns6:FurnitureFittings2019-12-31SC223422ns6:MotorVehicles2019-12-31SC223422ns6:ComputerEquipment2019-12-31SC223422ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-12-31SC223422ns6:CurrentFinancialInstrumentsns6:WithinOneYear2019-12-31SC223422ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2020-12-31SC223422ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2019-12-31SC223422ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2020-12-31SC223422ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2019-12-31SC223422ns11:Director112019-12-31SC223422ns11:Director112018-12-31SC223422ns11:Director112020-01-012020-12-31SC223422ns11:Director112019-01-012019-12-31SC223422ns11:Director112020-12-31SC223422ns11:Director112019-12-31SC2234222ns11:Director22019-12-31SC2234222ns11:Director22018-12-31SC2234222ns11:Director22020-01-012020-12-31SC2234222ns11:Director22019-01-012019-12-31SC2234222ns11:Director22020-12-31SC2234222ns11:Director22019-12-31SC223422ns11:Director332019-12-31SC223422ns11:Director332018-12-31SC223422ns11:Director332020-01-012020-12-31SC223422ns11:Director332019-01-012019-12-31SC223422ns11:Director332020-12-31SC223422ns11:Director332019-12-31
REGISTERED NUMBER: SC223422 (Scotland)















Unaudited Financial Statements for the Year Ended 31 December 2020

for

Pentland Medical Ltd.

Pentland Medical Ltd. (Registered number: SC223422)






Contents of the Financial Statements
for the Year Ended 31 December 2020




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Pentland Medical Ltd.

Company Information
for the Year Ended 31 December 2020







DIRECTORS: Mr S Munro
Mr J Munro
Mr R Munro





REGISTERED OFFICE: 157 Broomhall Crescent
Edinburgh
Midlothian
EH12 7PJ





REGISTERED NUMBER: SC223422 (Scotland)





ACCOUNTANTS: One Accounting Ltd
Chartered Management Accountants
Drumsheugh Toll
2 Belford Road
Edinburgh
Midlothian
EH4 3BL

Pentland Medical Ltd. (Registered number: SC223422)

Statement of Financial Position
31 December 2020

31.12.20 31.12.19
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 13,865 16,773
Tangible assets 5 117,674 156,489
131,539 173,262

CURRENT ASSETS
Stocks 190,158 157,385
Debtors 6 345,394 334,300
Cash at bank and in hand 204,876 102,768
740,428 594,453
CREDITORS
Amounts falling due within one year 7 160,042 191,409
NET CURRENT ASSETS 580,386 403,044
TOTAL ASSETS LESS CURRENT
LIABILITIES

711,925

576,306

CREDITORS
Amounts falling due after more than one
year

8

(294,033

)

(103,457

)

PROVISIONS FOR LIABILITIES (21,942 ) (29,239 )
NET ASSETS 395,950 443,610

CAPITAL AND RESERVES
Called up share capital 140 140
Retained earnings 395,810 443,470
SHAREHOLDERS' FUNDS 395,950 443,610

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2021 and were signed on its behalf by:



Mr S Munro - Director


Pentland Medical Ltd. (Registered number: SC223422)

Notes to the Financial Statements
for the Year Ended 31 December 2020

1. STATUTORY INFORMATION

Pentland Medical Ltd. is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the purchase of contracted commission payments in 2011, is being amortised over its' estimated useful life of 5 years .

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of eight years.

Patents and licences, being the amount paid in 2017 and 2018, is being amortised over its' estimated useful life of 8 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Fixtures and fittings - 25% on reducing balance
Motor vehicles - 20% on cost
Computer equipments - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties.

Debt instruments, including loans and other accounts receivable and payable are initially measured at transaction price adjusted for transaction costs. They are subsequently recognised at amortised costs using the effective interest method.

Creditors payable within one year, typically trade payables, are measured initially and subsequently at the undiscounted amount of the cash or other consideration expected to be paid.

Debtors payable within one year, typically trade receivables, are measured initially and subsequently at the undiscounted amount of the cash or other consideration expected to be received.


Pentland Medical Ltd. (Registered number: SC223422)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2020

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2019 - 7 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
At 1 January 2020
and 31 December 2020 15,000 23,265 38,265
AMORTISATION
At 1 January 2020 15,000 6,492 21,492
Charge for year - 2,908 2,908
At 31 December 2020 15,000 9,400 24,400
NET BOOK VALUE
At 31 December 2020 - 13,865 13,865
At 31 December 2019 - 16,773 16,773

Pentland Medical Ltd. (Registered number: SC223422)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2020

5. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Motor Computer
machinery fittings vehicles equipments Totals
£    £    £    £    £   
COST
At 1 January 2020 9,663 17,588 187,905 18,083 233,239
Additions - 203 - 3,007 3,210
At 31 December 2020 9,663 17,791 187,905 21,090 236,449
DEPRECIATION
At 1 January 2020 7,977 13,501 40,289 14,983 76,750
Charge for year 1,158 1,057 37,581 2,229 42,025
At 31 December 2020 9,135 14,558 77,870 17,212 118,775
NET BOOK VALUE
At 31 December 2020 528 3,233 110,035 3,878 117,674
At 31 December 2019 1,686 4,087 147,616 3,100 156,489

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.20 31.12.19
£    £   
Trade debtors 189,047 246,701
Amounts owed by group undertakings 101,282 37,500
Other debtors - S455 4,800 7,321
Other debtors 3,840 3,840
Directors' current accounts 14,925 17,870
Prepayments and accrued income 31,500 21,068
345,394 334,300

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.20 31.12.19
£    £   
Bank loans and overdrafts 23,633 -
Hire purchase contracts 18,139 17,831
Trade creditors 17,234 84,347
Other Loans 17,652 17,652
Tax 8,335 30,902
VAT 61,256 27,779
Other creditors 1,502 5,096
Credit card 1,967 1,544
Directors' current accounts 5,008 346
Accrued expenses 5,316 5,912
160,042 191,409

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.12.20 31.12.19
£    £   
Bank loans - 1-2 years 59,004 -
Bank loans - 2-5 years 167,363 -
Hire purchase contracts - 18,139
Other Loans 67,666 85,318
294,033 103,457

9. CONTINGENT LIABILITIES

At the year end there were no contingent liabilities.

Pentland Medical Ltd. (Registered number: SC223422)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2020

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2020 and 31 December 2019:

31.12.20 31.12.19
£    £   
Mr S Munro
Balance outstanding at start of year (345 ) (248 )
Amounts advanced 15,660 9,650
Amounts repaid (20,323 ) (9,747 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,008 ) (345 )

Mr J Munro
Balance outstanding at start of year 9,920 (670 )
Amounts advanced 6,201 15,165
Amounts repaid (4,000 ) (4,575 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,121 9,920

Mr R Munro
Balance outstanding at start of year 7,949 6,648
Amounts advanced 4,346 3,031
Amounts repaid (9,491 ) (1,730 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,804 7,949

These loans are interest free and repayable on demand.

11. RELATED PARTY DISCLOSURES

During the year, total dividends of £45,500 (2019 - £43,075) were paid to the directors .

The company was owed £101,282 (2019 - £37,500) by Innovel Ltd at the year end date. This loan is interest free and repayable on demand.

12. ULTIMATE CONTROLLING PARTY

The controlling party is Pentland Medical Holdings Ltd.

Stewart Munro is the ultimate controlling party due to his majority shareholding in the parent company.